A Mega-Merger Among Physicians
The proposed merger between PhyCor and MedPartners illustrates one of the most interesting phenomena for suppliers in the changing health care delivery scene--the growing clout of organizations created to give physicians more power in deciding where and how care is provided.
You may also be interested in...
Sandoz is benefiting from its focus on a “pure play” generics and biosimilars model that is unique among its peers, CEO Richard Saynor tells Generics Bulletin in an exclusive interview.
The dispute over a likely 60% reduction in supplies of AstraZeneca's COVID-19 vaccine shows no sign of resolution.
In December, a California federal court ordered the US Environmental Protection Agency to amend its TSCA Chemical Data Reporting rule to address asbestos information-gathering “loopholes,” including a current exemption for asbestos that occurs as an impurity in raw materials such as cosmetic talc.